small molecule

LUPRON DEPOT

LEUPROLIDE ACETATE

Loss of exclusivityFebruary 2031latest FDA-listed patent expiry
CompanyABBVIE ENDOCRINE INC

Drug detail

Brand nameLUPRON DEPOT
Active ingredientLEUPROLIDE ACETATE
Strength45MG
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalJune 2011
Marketing statusRX

Listed patents

PatentExpiresType
8921326February 2031product
9617303March 2028use U-4001

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.